Koninklijke Philips NV (PHG)
32.74
+1.17
(+3.71%)
USD |
NYSE |
Sep 27, 16:00
32.73
-0.01
(-0.03%)
After-Hours: 20:00
Koninklijke Philips Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2016 | -1.929B |
| September 30, 2016 | 1.169B |
| June 30, 2016 | -968.14M |
| March 31, 2016 | -90.46M |
| December 31, 2015 | -40.87M |
| September 30, 2015 | -174.38M |
| June 30, 2015 | -418.55M |
| March 31, 2015 | 1.221B |
| December 31, 2014 | -668.09M |
| September 30, 2014 | 130.66M |
| June 30, 2014 | -649.18M |
| March 31, 2014 | -394.56M |
| December 31, 2013 | -191.43M |
| September 30, 2013 | -343.90M |
| June 30, 2013 | -788.08M |
| March 31, 2013 | -324.76M |
| December 31, 2012 | -311.68M |
| September 30, 2012 | -296.14M |
| June 30, 2012 | -1.080B |
| March 31, 2012 | 1.311B |
| December 31, 2011 | -12.55M |
| September 30, 2011 | -755.79M |
| June 30, 2011 | -1.555B |
| March 31, 2011 | -172.35M |
| December 31, 2010 | 167.19M |
| Date | Value |
|---|---|
| September 30, 2010 | 7.184M |
| June 30, 2010 | -347.23M |
| March 31, 2010 | 44.28M |
| December 31, 2009 | -186.42M |
| September 30, 2009 | 42.72M |
| June 30, 2009 | -906.35M |
| March 31, 2009 | 290.04M |
| December 31, 2008 | -279.20M |
| September 30, 2008 | -1.191B |
| June 30, 2008 | -5.264B |
| March 31, 2008 | 1.487B |
| December 31, 2007 | -13.93M |
| September 30, 2007 | -1.331B |
| June 30, 2007 | -1.508B |
| March 31, 2007 | -398.28M |
| December 31, 2006 | -1.830B |
| September 30, 2006 | -1.951B |
| June 30, 2006 | -744.92M |
| March 31, 2006 | -141.95M |
| December 31, 2005 | -815.15M |
| September 30, 2005 | -484.33M |
| June 30, 2005 | -1.208B |
| March 31, 2005 | -712.18M |
| December 31, 2004 | -274.54M |
| September 30, 2004 | -1.567B |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 24.51M |
| argenx SE | 40.07M |
| NuCana PLC | -0.0888M |
| NewAmsterdam Pharma Co NV | 4.658M |
| uniQure NV | 0.05M |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow Yield | 1.45% |